Table 1.

Distribution of nuclear and cytoplasmic YAP and TAZ positivity in human CCA subtypes

iCC (152)	YAP	TAZ	YAP or TAZ	YAP and TAZ
nuclear	60 (39.5%)	48 (31.6%)	66 (43.4%)	21 (13.8%)
cytoplasmic	43 (28.3%)	4 (2.6%)	43 (28.3%)	2 (1.3%)
nuc. and cytopl.	68 (44.7%)	49 (32.2%)	69 (45.4%)	24 (15.8%)
pCC (155)	YAP	TAZ	YAP or TAZ	YAP and TAZ
nuclear	65 (41.9%)	55 (35.5%)	50 (32.3%)	35 (22.6%)
cytoplasmic	48 (31%)	3 (1.9%)	49 (31.6%)	1 (0.6%)
nuc. and cytopl.	76 (49%)	57 (36.8%)	57 (36.8%)	38 (24.5%)
dCC (126)	YAP	TAZ	YAP or TAZ	YAP and TAZ
nuclear	37 (29.4%)	83 (65.9%)	62 (49.2%)	29 (23%)
cytoplasmic	39 (31%)	6 (4.8%)	43 (34.1%)	1 (0.8%)
nuc. and cytopl.	55 (43.7%)	84 (66.7%)	55 (43.7%)	42 (33.3%)